Rioja Toro 2012.
Study characteristics | ||
Methods | Study design: a prospective, blinded, randomised, placebo‐controlled study Setting: Traumatology and Rehabilitation Service, Spain |
|
Participants |
Details of sampling frame: Total n eligible = not reported Total n excluded pre‐randomisation = not reported Total n randomised = 49 (98 hands) Total n available for follow‐up = unclear Total n analysed = 86 hands Intervention group 1 (splint & real laser) n = 22 hands Intervention group 2 (splint & placebo laser) n = 23 hands Intervention group 3 (real laser) n = 24 hands Intervention group 4 (placebo laser) n = 17 hands Gender distribution: Total: 3 males; 46 females Intervention group 1 (splint & real laser): not reported Intervention group 2 (splint & placebo laser): not reported Intervention group 3 (real laser): not reported Intervention group 4 (placebo laser): not reported Mean ± SD (range) age: Total: 49 ± 11.1 Intervention group 1 (splint & real laser): not reported Intervention group 2 (splint & placebo laser): not reported Intervention group 3 (real laser): not reported Intervention group 4 (placebo laser): not reported Mean ± SD (range) duration of CTS symptoms: Not reported Inclusion criteria:
Exclusion criteria:
CTS diagnostic criteria (case definition): 1. The diagnostic criteria are those recommended by the American Academy of Emergency Medicine: 1.1. Sensory latency difference (degree of CTS: mild < 0.5 ms; moderate 0.5‐0.8 ms; severe > 0.8 ms or not evoked) 1.2. Spontaneous activity at rest (degree of CTS: mild ‐ not; moderate ‐ not; severe ‐ yes (sometimes)) 1.3. Voluntary activity (degree of CTS: mild ‐ normal; moderate ‐ normal; severe ‐ neurogenic pattern) 1.4. DML (degree of CTS: mild ‐ normal; moderate ‐ normal or slight increase; severe ‐ augmented) 1.5. Motor potential synchronisation (degree of CTS: mild ‐ yes; moderate ‐ yes; severe ‐ desynchronised or decreased in amplitude, or both) 1.6. Motor driving speed (degree of CTS: mild ‐ normal; moderate ‐ normal; severe ‐ diminished) CTS severity: Mild‐to‐moderate CTS |
|
Interventions | Group 1 ‐splint during night & laser treatment Group 2 ‐ splint during night & placebo Group 3 ‐ laser treatment Group 4 ‐ control (placebo laser) For participants wearing splint: wrist orthosis with palmar metal strap was used (night‐time), without encompassing the metacarpophalangeal joints and in a neutral wrist position (0° position). In all participants treated with real laser, a total energy dose of 945 J was used in an area of 4 x 4 cm2 (59 J/cm2) and of 5 J of total dose in the same area of 4 x 4 cm2 (0.3 J/cm2) in the treatments with placebo laser. The rhythm of the sessions has been 5 per week for 4 weeks. In all of them, a careful cleaning of the skin was carried out prior to each treatment session, to avoid losses due to reflection. All participants had either not started treatment with NSAIDs, or had stopped at least 1 month before. None were undergoing local treatments with iontophoresis, ultrasounds, etc., or they had abandoned it more than a month ago. |
|
Outcomes | Outcomes evaluated before treatment and 1 and 3 months after treatment
|
|
Funding | Not reported | |
COI | The authors declared that they had no conflict of interest. | |
Notes | Article in Spanish, translation used The number of participants and hands reported in the main text and table 6 seems to be not the same ‐ we used data from table 6, assuming that the table 6 reported hands. |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Quote: "The patients who passed the selection of units A and B, went to unit C (physiotherapy) where, randomly, one wrist was treated with Lv and the other with Lp (total 49 hands with Lv and 49 hands with Lp). Also, 27 patients were randomly indicated to use a wrist orthosis with palmar metal strap (night use), without encompassing the metacarpophalangeal joints and in a neutral wrist position (0°position); in 15 of them the orthosis was put on the most affected hand, and in 12 on both hands (total 39 hands with orthosis)." Comment: Not clear how the randomisation was done |
Allocation concealment (selection bias) | Unclear risk | Comment: No information regarding the method of allocation was reported. |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Comment: Blinding of real laser versus placebo laser probably possible, however, it is unlikely that blinding for orthosis was possible. |
Blinding of outcome assessment (detection bias) All outcomes | High risk | Comment: Due to the nature of the interventions, it is likely that participants were aware of which treatment they were allocated to, therefore we rated the risk as high. |
Incomplete outcome data (attrition bias) 3 months or less | Unclear risk | Comment: No flowchart and not completely clear if all participants were followed up or if the authors only reported data for those that participated in the follow‐up visits. |
Incomplete outcome data (attrition bias) After 3 months | Unclear risk | Comment: Numbers of participants not reported |
Selective reporting (reporting bias) | Unclear risk | Comment: The outcomes were reported incompletely (only as P values from statistical analysis). |
Other bias | Unclear risk | Comment: 49 participants had bilateral CTS (98 hands). The unit of analysis (hand or participant) was unclear, as the tables reported data for 86 participants. |